<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Linkoping_Sweden_Protein skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Linkoping Sweden/Protein</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="html-menu-container"><DIV id="html-menu-right"><DIV id="html-menu"><A class="menu-selected" href="https://2015.igem.org/Team:Linkoping_Sweden/Description">Project</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Team">Team</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Modeling">Modeling</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Practices">Policy and Practice</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Detector">Detector</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Notebook">Notebook</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Results">Result</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Safety">Safety</A></DIV><DIV id="html-sub-menu"><A href="https://2015.igem.org/Team:Linkoping_Sweden/Description">Description</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Protein">The Protein</A><A href="https://2015.igem.org/Team:Linkoping_Sweden/Poster">Poster</A></DIV></DIV></DIV><DIV id="content-container" class="container"><DIV class="row"><H3>The Protein</H3><DIV class="col-xs-6"><P>
                    The protein is a composition of the biobricks BBa_E1010 (red fluorescent protein, RFP) and
                    BBa_K525998 (promotor T7 and RBS) which are inserted together with Epitope 2 from Ara h 1 into a
                    psb1c3-vector.
                </P><P>
                    When digesting and ligating the biobricks in order to obtain the desired sequence, a stop codon
                    appeared between the biobricks, this problem was solved using single point mutagenesis where the
                    stop codon was exchanged with leucine. Leucine is a small amino acid with an unpolar side chain and
                    will therefore have a very small impact on the protein.
                </P><P>
                    To avoid misfolding of the protein, a linker composed of the amino acids glycine and serine is used
                    to separate the epitope from RFP. Glycine is a small amino acid and provides flexibility<SUP>1</SUP> to the
                    linker while serine adds stability<SUP>2</SUP>.
                </P></DIV><DIV class="col-xs-6"><P>
                    GS-linker is used to separate the epitope sequence from RFP.
                </P><P>
                    Epitope 2 was chosen due to its location on the surface of the Ara h 1 allowing the antibodies to
                    recognize the sequence in it’s native form unlike epitopes located on the inside of Ara h 1 which
                    can only be recognized when the full length protein has been denatured.
                </P><P>
                    The antibodies which the protein construct is supposed to bind to are monoclonal and specific for
                    epitope 2. These antibodies are conjugated with three to six fluorescein isothiocyanate (FITC)
                    molecules which absorbs light at 495 nm and emits at 519 nm. If RFP is close enough it can absorb
                    the light emitted by FITC and emit light at a higher wavelength; 607 nm. This phenomenon is called
                    Förster resonance energy transfer (FRET).
                </P></DIV></DIV><DIV class="row"><H3>Amino acid sequence</H3><DIV class="col-xs-6"><P>The epitopes amino acid sequence and an explanation of its building blocks:</P><P style="word-break: break-all;">
                    M<SPAN style="color: #0C0;">HHHHHH</SPAN>SSGVDLGT<SPAN style="color: #F00;">ENLYFQS</SPAN>M<SPAN style="color: #00F;">QEPDDLKQKA</SPAN><SPAN style="color: #F0F;">GSGSGSGSGS</SPAN>YLMASSEDVIKEFMRFKVRMEGSVNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWDILSPQFQYGSKAYVKHPADIPDYLKLSFPEGFKWERVMNFEDGGVVTVTQDSSLQDGEFIYKVKLRGTNFPSDGPVMQKKTMGWEASTERMYPEDGALKGEIKMRLKLKDGGHYDAEVKTTYMAKKPVQLPGAYKTDIKLDITSHNEDYTIVEQYERAEGRHSTGA**R**C*CRSLLVAAAA
                </P><P class="protein-seq" style="color: #0C0;">
                    HHHHHH
                </P><P class="protein-seq-desc">
                    The Histidine tag which is used in order to simplify the
                    purification of the protein when loaded onto a nickel column.
                </P><P class="protein-seq" style="color: #F00;">
                    ENLYFQS
                </P><P class="protein-seq-desc">
                    Tev protease recognision site which cuts the His-tag.
                </P><P class="protein-seq" style="color: #00F;">
                    QEPDDLKQKA
                </P><P class="protein-seq-desc">
                    Epitope 2 from Ara h 1.
                </P><P class="protein-seq" style="color: #F0F;">
                    GSGSGSGSGS
                </P><P class="protein-seq-desc">
                    GS-linker used to separate epitope 2 and RFP to avoid misfolding
                </P><P class="protein-seq">
                    *
                </P><P class="protein-seq-desc">
                    Stop codon
                </P><P>   The rest of the sequence is RFP from the biobrick E1010. This creates the protein complex of epitope
                    and RFP, shown i Figure 1.
                </P></DIV><DIV class="col-xs-6"><P class="caption"><B>Figure 1.</B> Prediction of the three-dimensional structure model of the full protein complex obtained from I-Tasser.<SUP>3</SUP></P></DIV></DIV><DIV class="row"><H3>References</H3><DIV class="col-xs-12"><UL class="list-unstyled"><LI><B>1.</B> Ryan Trinh, Brian Gurbaxani, Sherie L Morrison, Manouchehr Seyfzadeh (2004). Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression</LI><LI><B>2.</B> Clifford R. Robinson, Robert T. Sauer (1998). Optimizing the stability of single-chain proteins by linker length and composition mutagenesis</LI><LI><B>3.</B><A href="http://zhanglab.ccmb.med.umich.edu/I-TASSER/output/S240383/w25vap/" target="_blank">http://zhanglab.ccmb.med.umich.edu/I-TASSER/output/S240383/w25vap/</A></LI></UL></DIV></DIV></DIV><DIV id="footer"><DIV class="container"><DIV class="col-xs-3"><B>Linköping University</B><UL class="list-unstyled"><LI><A href="http://www.liu.se/om-liu?l=en" target="_blank">About Linköping University</A></LI><LI><A href="http://www.liu.se/forskning/forskningsomraden?l=en" target="_blank">Research areas</A></LI><LI><A href="http://www.liu.se/utbildning/exchange-students?l=en" target="_blank">Study abroad</A></LI></UL></DIV><DIV class="col-xs-offset-2 col-xs-3"><B>LiU iGEM</B><UL class="list-unstyled"><LI>Linköping University</LI><LI>581 83 Linköping</LI><LI>Sweden</LI></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>